Search results
Showing 7636 to 7650 of 8216 results
Details and meeting dates of the antimicrobials evaluation panel
Preparing for the next breakthroughs in liver disease treatments
With no licensed treatments for MASH, a serious liver condition affecting 3 million in the UK, NICE has co-developed a framework with patients, clinicians, and industry to accelerate access to promising new medicines.
Our landmark review demonstrates a new approach to keeping NHS care up-to-date and could benefit thousands of adults with metastatic prostate cancer.
Tell us what matters to you, your organisation or your community.
Home About us Our board Public board meetings...
Agenda and papers of the NICE public board meeting on 19 January 2022
Home About us Our board Public board meetings...
Agenda and papers of the NICE public board meeting on 22 March 2023
Home About us Our board Public board meetings...
Agenda and papers of the NICE public board meeting on 20 March 2024
Agenda and papers of the NICE public board meeting on 19 March 2025
Home Get involved Our committees...
To support use of up-to-date content, and drive sustainability and digital transformation, the upcoming editions of BNF and BNFC (scheduled for distribution in October and November 2023) will be the last print editions to be supplied to the NHS in England by NICE.
This agreement constitutes the entire agreement between the Organisation and NICE relating to the Confidential Information
The NICE board sets out our strategic priorities and policies.